Free Trial

Hyperfine (HYPR) Competitors

Hyperfine logo
$0.73 +0.01 (+0.69%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$0.73 0.00 (-0.27%)
As of 05/1/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HYPR vs. PDEX, NVRO, LUNG, NYXH, RCEL, CVRX, ELMD, INGN, AVR, and DRTS

Should you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Pro-Dex (PDEX), Nevro (NVRO), Pulmonx (LUNG), Nyxoah (NYXH), AVITA Medical (RCEL), CVRx (CVRX), Electromed (ELMD), Inogen (INGN), Anteris Technologies Global (AVR), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

Hyperfine vs.

Pro-Dex (NASDAQ:PDEX) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking.

15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 47.5% of Pro-Dex shares are held by insiders. Comparatively, 31.0% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Pro-Dex has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.

Pro-Dex presently has a consensus target price of $52.00, indicating a potential downside of 22.73%. Hyperfine has a consensus target price of $1.33, indicating a potential upside of 82.19%. Given Hyperfine's higher possible upside, analysts plainly believe Hyperfine is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Hyperfine
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Pro-Dex had 3 more articles in the media than Hyperfine. MarketBeat recorded 5 mentions for Pro-Dex and 2 mentions for Hyperfine. Hyperfine's average media sentiment score of 1.44 beat Pro-Dex's score of 0.94 indicating that Hyperfine is being referred to more favorably in the news media.

Company Overall Sentiment
Pro-Dex Positive
Hyperfine Positive

Pro-Dex has a net margin of 11.06% compared to Hyperfine's net margin of -309.42%. Pro-Dex's return on equity of 21.68% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex11.06% 21.68% 12.40%
Hyperfine -309.42%-57.54%-50.38%

Pro-Dex has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$61.00M3.60$2.13M$2.0133.48
Hyperfine$12.89M4.41-$44.24M-$0.56-1.30

Pro-Dex received 149 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 61.75% of users gave Pro-Dex an outperform vote while only 50.00% of users gave Hyperfine an outperform vote.

CompanyUnderperformOutperform
Pro-DexOutperform Votes
155
61.75%
Underperform Votes
96
38.25%
HyperfineOutperform Votes
6
50.00%
Underperform Votes
6
50.00%

Summary

Pro-Dex beats Hyperfine on 13 of the 18 factors compared between the two stocks.

Get Hyperfine News Delivered to You Automatically

Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HYPR vs. The Competition

MetricHyperfineElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$56.82M$3.18B$5.53B$7.93B
Dividend YieldN/A1.80%5.11%4.22%
P/E Ratio-1.2815.4222.5118.54
Price / Sales4.4155.55397.62103.30
Price / CashN/A44.0938.1834.62
Price / Book0.623.536.734.25
Net Income-$44.24M$94.03M$3.22B$248.18M
7 Day Performance-3.57%1.00%1.38%1.03%
1 Month Performance-0.68%4.45%2.79%2.70%
1 Year Performance-7.93%-18.19%15.41%4.05%

Hyperfine Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HYPR
Hyperfine
3.5811 of 5 stars
$0.73
+0.7%
$1.33
+82.2%
-8.9%$56.82M$12.89M-1.28190Short Interest ↓
PDEX
Pro-Dex
1.4247 of 5 stars
$69.00
+6.3%
$52.00
-24.6%
+261.6%$225.01M$61.00M34.33140Earnings Report
Short Interest ↑
News Coverage
High Trading Volume
NVRO
Nevro
0.1892 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-43.8%$224.32M$408.52M-3.091,090Upcoming Earnings
Analyst Forecast
LUNG
Pulmonx
3.731 of 5 stars
$5.19
-0.2%
$12.75
+145.7%
-51.2%$208.88M$83.79M-3.60250Earnings Report
Upcoming Earnings
Analyst Forecast
News Coverage
Gap Up
NYXH
Nyxoah
2.2831 of 5 stars
$6.01
+2.4%
$14.50
+141.3%
-36.6%$204.70M$4.52M-3.21110
RCEL
AVITA Medical
1.6879 of 5 stars
$10.25
+1.8%
$17.25
+68.3%
+8.0%$198.26M$64.25M-4.29130Upcoming Earnings
Positive News
CVRX
CVRx
3.1145 of 5 stars
$7.52
+11.7%
$16.83
+123.8%
-28.0%$195.79M$51.29M-2.80160Upcoming Earnings
Short Interest ↓
News Coverage
Positive News
High Trading Volume
ELMD
Electromed
0.6146 of 5 stars
$22.87
-0.8%
$38.00
+66.2%
+30.6%$195.70M$59.63M30.49160Analyst Upgrade
INGN
Inogen
2.5599 of 5 stars
$7.27
-0.1%
$7.00
-3.7%
+0.1%$195.47M$335.71M-3.231,030Upcoming Earnings
Short Interest ↑
Positive News
AVR
Anteris Technologies Global
N/A$5.39
+8.2%
$16.50
+206.1%
N/A$194.17M$2.71M0.00138News Coverage
Positive News
High Trading Volume
DRTS
Alpha Tau Medical
2.036 of 5 stars
$2.64
flat
$8.00
+203.0%
+7.8%$185.81MN/A-6.1480Analyst Forecast
Analyst Revision
News Coverage
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:HYPR) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners